Matrix metalloproteinase-7 as a marker of metastasis and predictor of poor survival in bladder cancer

Cancer Science

Volumn 101, Issue 5, 2010, Pages 1300-1308

  Szarvas, Tibor ^a   Becker, Markus ^a   vom Dorp, Frank ^a   Gethmann, Carolin ^a   Tötsch, Martin ^b   Bánkfalvi, Ágnes ^b   Schmid, Kurt W ^b   Romics, Imre ^c   Rübben, Herbert ^a   Ergün, Süleyman ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

MATRILYSIN; MESSENGER RNA;

ADULT; ARTICLE; BLADDER CANCER; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 77953182449     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01506.x     Document Type: Article

References (30)

1. Stein JP, Skinner DG. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J Urol 2006, 24:296-304.
2. Bochner BH, Montie JE, Lee CT. Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am 2003, 30:777-89.
3. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR Am J Roentgenol 2000, 175:759-66.
4. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-4.
5. Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM. Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 2002, 408:155-61.
6. Lee KH, Choi EY, Hyun MS. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Eur Surg Res 2007, 39:208-15.
7. von Bredow DC, Nagle RB, Bowden GT, Cress AE. Cleavage of beta 4 integrin by matrilysin. Exp Cell Res 1997, 236:341-5.
8. Ito TK, Ishii G, Saito S. Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 2009, 113:2363-9.
9. Dong Z, Kumar R, Yang X, Fidler IJ. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997, 88:801-10.
10. Cornelius LA, Nehring LC, Harding E. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J Immunol 1998, 161:6845-52.
11. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaissé J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000, 486:247-51.
12. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003, 22:145-52.
13. Harrell PC, McCawley LJ, Fingleton B, McIntyre JO, Matrisian LM. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp Cell Res 2005, 303:308-20.
14. Miyata Y, Iwata T, Ohba K, Kanda S, Nishikido M, Kanetake H. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin Cancer Res 2006, 12:6998-7003.
15. Jones LE, Humphreys MJ, Campbell F, Neoptolemos JP, Boyd MT. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin Cancer Res 2004, 10:2832-45.
16. Yamamoto H, Iku S, Adachi Y. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J Pathol 2003, 199:176-84.
17. Yamamoto H, Adachi Y, Itoh F. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res 1999, 59:3313-6.
18. Maurel J, Nadal C, Garcia-Albeniz X. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer 2007, 121:1066-71.
19. Ramankulov A, Lein M, Johannsen M, Schrader M, Miller K, Jung K. Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas. Cancer Sci 2008, 99:1188-94.
20. Eble JN, Epstein JI, Sesterhenn I. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs 2004, 89-158. Lyon, IARCC Press
21. Ohl F, Jung M, Radonic A, Sachs M, Loening SA, Jung K. Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer. J Urol 2006, 175:1915-20.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-8.
23. Kioi M, Yamamoto K, Higashi S, Koshikawa N, Fujita K, Miyazaki K. Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model. Oncogene 2003, 22:8662-70.
24. Sumi T, Yoshida H, Hyun Y. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder. Oncol Rep 2003, 10:345-9.
25. Takahashi T, Habuchi T, Kakehi Y. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. Cancer Res 1998, 58:5835-41.
26. Zeng ZS, Shu WP, Cohen AM, Guillem JG. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 2002, 8:144-8.
27. vom Dorp F, Börgermann C, Schenck M. Role of lymphadenectomy in patients with invasive urothelial carcinoma of the bladder. Urologe A 2009, 48:51-3.
28. Lerner SP, Skinner DG, Lieskovsky G. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 1993, 149:758-64.
29. Herr HW, Donat SM. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001, 165:62-4.
30. Persad R, Kabala J, Gillatt D, Penry B, Gingell JC, Smith PJ. Magnetic resonance imaging in the staging of bladder cancer. Br J Urol 1993, 71:566-73.